Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2003; 89(02): 235-242
DOI: 10.1055/s-0037-1613437
DOI: 10.1055/s-0037-1613437
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Effect of factor VIII on tissue factor-initiated spatial clot growth
Further Information
Publication History
Received
04 March 2002
Accepted after resubmission
07 November 2002
Publication Date:
07 December 2017 (online)
Summary
Using time-lapse videomicroscopy, we studied the role of coagulation factor VIII (fVIII) in tissue factor-initiated spatial clot growth on fibroblast monolayers in a thin layer of non-stirred recalcified plasma from healthy donors or patients with severe Haemophilia A. Analysis of temporal evolution of light-scattering profiles from a growing clot revealed existence of two phases in the clot growth-initiation phase in a narrow (0.2 mm) zone adjacent to activator surface and elongation phase in plasma volume. While the initiation phase did not differ in normal and haemophilic plasmas, the rate of clot growth in the elongation phase in haemophilic plasma constituted only 30% of that in normal plasma. Supplementation of haemophilic plasma with 0.05 U/ml fVIII restored the normal clot growth rate (44.9 ± 2.5 μm/min) at high but not at low fibroblast density. Our results indicate that the functioning of the intrinsic tenase complex is critical for normal spatial clot growth.
-
References
- 1 Roberts HR, Jones MR. Hemophilia and related conditions – congenital deficiencies of prothrombin (factor II), factor V, factors VII to XII. In: Hematology, 4th edn. Williams WJ, Beutler E, Erslev AJ, Lichtman M. eds New York: McGraw-Hill Publishing Co; 1994: 1453-74.
- 2 Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-74.
- 3 Rapaport SI, Rao LVM. The tissue factor pathway: How it has become a “prima ballerina”. Thromb Haemost 1995; 74: 7-17.
- 4 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
- 5 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
- 6 Xi M, Beguin S, Hemker HC. Importance of factor-IX-dependent prothrombinase formation – the Josso pathway – in clotting plasma. Haemostasis 1989; 19: 301-8.
- 7 Cawthern KM, van'tVeer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
- 8 He R, Xiong S, He X, Liu F, Han J, Li J, He S. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway. Thromb Haemost 2001; 85: 1055-9.
- 9 Repke D, Gemmell CH, Guha A, Turitto VT, Broze Jr GJ, Nemerson Y.. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci USA 1990; 87: 7623-7.
- 10 Hoffman M, Monroe 3rd DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
- 11 Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-7.
- 12 Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh 1965; 17: 35-44.
- 13 Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Nat Acad Sci 1977; 74: 5260-4.
- 14 Gailani D, Broze Jr GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
- 15 Zarnitsina VI, Pokhilko AV, Ataullakhanov FI. A mathematical model for the spatiotemporal dynamics of the intrinsic pathway of blood coagulation. II. Results. Thromb Res 1996; 84: 333-44.
- 16 Ataullakhanov FI, Guria GT, Sarbash VI, Volkova RI. Spatiotemporal dynamics of clotting and pattern formation in human blood. Biochim Biophys Acta 1998; 1425: 453-68.
- 17 Ovanesov MV, Krasotkina JV, Ul’yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob’ev AI, Ataullakhanov FI. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 2002; 1572 (01) 45-57.
- 18 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. Thromb Haemost 1991; 66: 384-6.
- 19 Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorr. 1975; 34: 612
- 20 Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into non-stirred citrate human plasma. Biochim Biophys Acta 1998; 1425: 607-16.
- 21 Mitropoulos KA, Martin JC, Stirling Y, Morrisey JH, Cooper JA. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Res 1995; 78: 67-75.
- 22 Muller AD, van Deijk WA, Devilee PP, van Dam-Mieras MC, Hemker HC. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII. Br J Haematol 1986; 62: 367-77.
- 23 Hojima Y, Pierce JV, Pisano J. Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res. 1980; 20: 149-62.
- 24 Saenko EL, Shima M, Gilbert GE, Scandella D. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-31.
- 25 Krasotkina YV, Sinauridze EI, Ataullakhanov FI. Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion. Biochim Biophys Acta 2000; 1474: 337-45.
- 26 Nilsson IM. Replacement therapy. In Hemophilia. Nilsson IM, Brenshop E, Lethagen S, Ljung R, Peterson C. eds Pharmacia: Plasma Products; 1994: 48-65.
- 27 Singh I, Smith A, Vanzieleghem B, Collen D, Burnand K, Saint-Remy JM, Jacquemin M.. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood 2002; May 1 99 (09) 3235-40.
- 28 Marlar RA, Kleiss AJ, Griffin JH. An alternative extrinsic pathway of human blood coagulation. Blood 1982; 60: 1353-8.
- 29 Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets. Blood Coagul Fibrinolysis. 1996; 7: 459-64.